Liquidia Corp

LQDA

Liquidia Corp

LQDA

Insider Sentiment (TTM):

Last Purchase:2026-05-19Last Sale:2026-06-22Shares Purchased (TTM):5,300Shares Sold (TTM):2,796,034

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:59,970,082Shares Outstanding:88,006,244Institutional Ownership Pct.:68.14%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	284	223	191	157	173	170	176	204	133	158	84	76
Accounts Receivable Net Current	109	74	54	36	10	1	3	4	3	3	4	3
Inventory Gross	-	-	-	-	-	-	-	-	7	4	-	-
Inventory Net	36	29	24	25	6	1	0	0	-	-	-	-
Prepaid Expense And Other Assets Current	9	8	5	9	6	5	6	6	4	4	2	3
Assets Current	438	333	273	227	196	177	185	214	147	168	90	83
Property Plant And Equipment Net	35	21	12	11	10	8	8	8	6	6	4	4
Operating Lease Right Of Use Asset	4	4	4	4	4	4	4	1	1	2	2	2
Intangible Assets Net Excluding Goodwill	3	3	3	3	3	3	3	3	3	3	3	3
Goodwill	4	4	4	4	4	4	4	4	4	4	4	4
Deferred Income Tax Assets Net	1	1	-	-	-	-	-	-	-	-	-	-
Restricted Cash Noncurrent	4	4	4	4	4	-	-	-	-	-	-	-
Other Assets Noncurrent	19	17	13	9	22	16	11	8	0	0	0	0
Assets	522	402	328	276	257	227	230	253	177	197	118	112
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	13	11	4	6	11	9	5	2	6	2	1	2
Operating Lease Liability Current	-	-	-	-	-	-	-	-	-	-	1	1
Finance Lease Liability Current	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities Current	189	150	136	103	78	61	42	34	24	22	19	12
Litigation Reserve Noncurrent	9	9	8	8	8	8	7	7	7	7	7	7
Operating Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	2	3
Deferred Income Tax Liabilities Net	1	1	-	-	-	-	-	-	-	-	-	-
Liabilities	327	293	283	254	242	178	151	142	115	100	71	64
Finance Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Stockholders Equity
Preferred Stock Value	-	0	-	0	0	0	-	0	0	0	-	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	694	682	671	663	652	645	637	632	561	556	476	450
Retained Earnings Accumulated Deficit	-499	-573	-626	-641	-637	-596	-557	-521	-498	-459	-429	-402
Stockholders Equity	195	109	45	22	15	50	79	113	73	97	47	48
Liabilities And Stockholders Equity	522	402	328	276	257	227	230	253	177	197	118	112
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	115	115	115	115	115	115	115	115	115	100	100	100
Common Stock Shares Issued	89	88	87	87	86	85	85	85	76	76	69	65
Shares Outstanding	89	88	87	87	86	85	85	85	76	76	69	65

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	16.41%	48.56%	58.31%	-	-	-	-	-	-	-	-	-
2025	-2.80%	-14.66%	27.69%	19.71%	-6.93%	1.08%	29.38%	36.44%	60.94%	1.48%	8.08%	76.65%
2024	13.43%	0.74%	-7.50%	-10.96%	-6.27%	3.09%	7.21%	19.67%	38.56%	-9.72%	2.28%	21.58%
2023	-	-	-	-	-	-	6.91%	76.91%	78.97%	6.65%	-13.17%	-12.63%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.31	2.22	2.01	2.20	2.49	2.93	4.43	6.33	6.08	7.66	4.85	6.83
Quick Ratio	2.07	1.98	1.80	1.88	2.34	2.83	4.29	6.16	5.63	7.32	4.73	6.55
Working Capital	248.41M	183.32M	137.63M	123.78M	117.17M	116.69M	143.32M	180.37M	123.04M	146.01M	71.35M	70.82M
Leverage & Debt
Debt to Equity	1.67	2.70	6.33	11.52	15.95	3.57	1.90	1.26	1.57	1.03	1.50	1.33
Interest Coverage TTM	6.33	1.75	-2.13	-4.93	-7.75	-8.66	-9.61	-11.07	-11.00	-12.11	-11.70	-10.67
Debt Ratio	0.63	0.73	0.86	0.92	0.94	0.78	0.66	0.56	0.65	0.51	0.60	0.57
Efficiency & Turnover
Asset Turnover TTM	1.16	0.92	0.57	0.26	0.09	0.07	0.08	0.09	0.10	0.10	0.14	0.15
Days Sales Outstanding TTM	47.98	47.77	65.49	105.89	124.84	49.25	88.41	88.15	90.32	76.59	94.74	64.50
Receivables Turnover TTM	7.61	7.64	5.57	3.45	2.92	7.41	4.13	4.14	4.04	4.77	3.85	5.66
Per Share Metrics
Diluted EPS TTM	1.37	0.22	-0.80	-1.41	-1.75	-1.60	-1.63	-1.50	-1.33	-1.28	-1.21	-0.89
Free Cash Flow Per Share TTM	0.78	0.47	-0.47	-0.85	-1.05	-1.22	-1.25	-1.18	-1.02	-0.79	-0.66	-0.49
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	97.20%	94.43%	92.24%	75.98%	58.08%	58.00%	64.65%	69.52%	76.82%	83.49%	85.87%
Operating Profit Margin TTM	37.39%	15.81%	-32.45%	-154.98%	-715.38%	-904.40%	-866.63%	-715.07%	-655.83%	-582.16%	-419.62%	-291.78%
Net Profit Margin TTM	30.74%	7.74%	-43.53%	-176.24%	-773.66%	-965.60%	-916.63%	-751.00%	-687.27%	-606.50%	-448.89%	-314.38%
Growth Metrics
Net Revenue Growth (1Y)	2,233.65%	1,936.66%	1,031.18%	343.41%	30.20%	-11.42%	-19.97%	-14.78%	-16.65%	-5.72%	9.75%	32.84%
Net Income Growth (1Y)	-192.72%	-116.33%	-46.28%	4.06%	46.57%	41.03%	63.42%	103.58%	100.43%	163.03%	91.40%	25.06%
EPS Growth (1Y)	-189.28%	-115.81%	-50.86%	-5.60%	30.89%	24.84%	34.95%	68.59%	69.89%	125.57%	79.52%	24.29%
Valuation Metrics
P/E TTM	51.13	148.91	-43.06	-16.09	-7.13	-9.20	-7.21	-6.68	-8.99	-11.48	-9.96	-7.14
P/B TTM	36.32	30.59	66.33	89.03	70.21	25.27	11.66	6.95	12.59	11.45	16.53	8.57
P/S TTM	15.72	11.53	18.75	28.36	55.19	88.82	66.13	50.17	61.81	69.65	44.71	22.45
Market Cap	7.09B	3.32B	2.97B	1.96B	1.07B	1.26B	925.60M	783.17M	917.23M	1.11B	781.87M	411.20M
Enterprise Value	6.80B	3.10B	2.78B	1.81B	893.01M	1.09B	749.12M	578.80M	784.14M	954.20M	698.36M	335.17M
Calculated Values
Free Cash Flow TTM	69.53M	41.15M	-40.02M	-73.32M	-89.47M	-103.89M	-98.37M	-92.46M	-77.67M	-59.52M	-42.85M	-31.76M
Net Debt	-284.18M	-222.79M	-190.68M	-157.50M	-173.42M	-169.76M	-176.48M	-204.37M	-133.09M	-157.86M	-83.51M	-76.03M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-22Sale

Owner: Bloch, Stephen M

Title: -

Shares: 100,000

Price/Share: $75.86

Value: $7,586,000.00

Shares Owned: 880,073

Relationship: Director

Ownership: Indirect

2026-06-15Sale

Owner: Bloch, Stephen M

Title: -

Shares: 85,062

Price/Share: $71.75

Value: $6,103,198.50

Shares Owned: 980,073

Relationship: Director

Ownership: Indirect

2026-06-11Sale

Owner: Krepp, Sarah

Title: Chief Human Resource Officer

Shares: 24,880

Price/Share: $70.28

Value: $1,748,566.40

Shares Owned: 121,863

Relationship: Officer

Ownership: Direct

2026-06-11Sale

Owner: Bloch, Stephen M

Title: -

Shares: 242,269

Price/Share: $69.76

Value: $16,900,685.44

Shares Owned: 1,176,184

Relationship: Director

Ownership: Indirect

2026-06-09Sale

Owner: Bloch, Stephen M

Title: -

Shares: 72,534

Price/Share: $64.76

Value: $4,697,301.84

Shares Owned: 1,564,407

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-22	Bloch, Stephen M	Director	-	Indirect	Sale	100,000	75.86	$7,586,000.00	880,073	4
2026-06-15	Bloch, Stephen M	Director	-	Indirect	Sale	85,062	71.75	$6,103,198.50	980,073	4
2026-06-11	Krepp, Sarah	Officer	Chief Human Resource Officer	Direct	Sale	24,880	70.28	$1,748,566.40	121,863	4
2026-06-11	Bloch, Stephen M	Director	-	Indirect	Sale	242,269	69.76	$16,900,685.44	1,176,184	4
2026-06-09	Bloch, Stephen M	Director	-	Indirect	Sale	72,534	64.76	$4,697,301.84	1,564,407	4
2026-06-08	Khindri, Sanjeev	Officer	Chief Development Officer	Direct	Sale	4,134	65.46	$270,611.64	67,132	4
2026-06-05	Bloch, Stephen M	Director	-	Indirect	Sale	2,064	64.14	$132,384.96	1,785,242	4
2026-06-04	Manning, Paul B	Director	-	Indirect	Sale	200,000	63.66	$12,732,000.00	716,311	4
2026-06-03	Kirsch, Arthur S	Director	-	Indirect	Sale	10,000	54.80	$548,000.00	0	4
2026-06-01	Krepp, Sarah	Officer	Chief Human Resource Officer	Direct	Sale	276	60.87	$16,800.12	146,743	4
2026-05-27	Jeffs, Roger	Director,Officer	Chief Executive Officer	Indirect	Sale	6,428	62.18	$399,693.04	1,041,667	4
2026-05-26	Jeffs, Roger	Director,Officer	Chief Executive Officer	Indirect	Sale	25,000	60.38	$1,509,500.00	1,048,095	4
2026-05-21	Singh, Raman	Director	-	Direct	Sale	29,494	60.13	$1,773,474.22	38,755	4
2026-05-20	Jeffs, Roger	Director,Officer	Chief Executive Officer	Indirect	Sale	25,000	61.30	$1,532,500.00	1,123,095	4
2026-05-19	Johnson, David Edward, Ca…	Director,TenPercentOwner,Other	-	Indirect	Purchase	5,300	59.98	$317,894.00	8,138,951	4
2026-05-19	Johnson, David Edward, Ca…	Director,TenPercentOwner,Other	-	Indirect	Sale	5,300	59.98	$317,894.00	8,133,651	4
2026-05-15	Jeffs, Roger	Director,Officer	Chief Executive Officer	Indirect	Sale	25,000	57.04	$1,426,000.00	1,198,095	4
2026-05-12	Jeffs, Roger	Director,Officer	Chief Executive Officer	Indirect	Sale	25,000	54.04	$1,351,000.00	1,273,095	4
2026-05-11	Bloch, Stephen M	Director	-	Indirect	Sale	318,893	50.85	$16,215,709.05	1,870,042	4
2026-05-07	Jeffs, Roger	Director,Officer	Chief Executive Officer	Indirect	Sale	25,000	42.09	$1,052,250.00	1,348,095	4
2026-04-27	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	1,576	37.78	$59,541.28	175,342	4
2026-04-27	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	688	41.65	$28,655.20	214,738	4
2026-04-17	Jeffs, Roger	Director,Officer	Chief Executive Officer	Indirect	Sale	18,839	40.60	$764,863.40	1,423,095	4
2026-04-16	Jeffs, Roger	Director,Officer	Chief Executive Officer	Indirect	Sale	25,000	40.31	$1,007,750.00	1,441,934	4
2026-04-15	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	139,390	40.14	$5,595,114.60	353,356	4
2026-04-13	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	7,301	38.37	$280,139.37	215,426	4
2026-04-13	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	9,220	38.37	$353,771.40	173,270	4
2026-04-13	Schundler, Russell	Officer	General Counsel	Direct	Sale	13,692	38.37	$525,362.04	610,532	4
2026-04-13	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	18,958	38.37	$727,418.46	405,775	4
2026-04-13	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	5,101	38.37	$195,725.37	176,918	4
2026-04-13	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Sale	32,744	38.37	$1,256,387.28	1,137,599	4
2026-04-13	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	10,547	38.28	$403,739.16	184,558	4
2026-04-13	Krepp, Sarah	Officer	Chief Human Resource Officer	Direct	Sale	4,557	38.37	$174,852.09	147,019	4
2026-04-09	Jeffs, Roger	Director,Officer	Chief Executive Officer	Indirect	Sale	25,000	40.12	$1,003,000.00	1,516,667	4
2026-04-09	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	133,789	40.24	$5,383,669.36	411,855	4
2026-03-27	Bloch, Stephen M	Director	-	Indirect	Sale	62,550	36.31	$2,271,190.50	2,188,935	4
2026-03-23	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	18,314	36.64	$671,024.96	187,640	4
2026-03-13	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	35,365	36.30	$1,283,749.50	174,473	4
2026-03-13	Singh, Raman	Director	-	Direct	Sale	20,000	36.04	$720,800.00	38,755	4
2026-03-13	Krepp, Sarah	Officer	Chief Human Resource Officer	Direct	Sale	16,261	38.00	$617,918.00	148,397	4
2026-03-09	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	80,000	35.32	$2,825,600.00	188,954	4
2026-03-02	Krepp, Sarah	Officer	Chief Human Resource Officer	Direct	Sale	276	30.58	$8,440.08	164,658	4
2026-03-02	Schundler, Russell	Officer	General Counsel	Direct	Sale	1,073	30.58	$32,812.34	614,057	4
2026-03-02	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	827	30.58	$25,289.66	188,954	4
2026-03-02	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	689	30.58	$21,069.62	212,479	4
2026-03-02	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	445	30.58	$13,608.10	178,840	4
2026-03-02	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	1,165	30.58	$35,625.70	411,855	4
2026-01-26	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	688	41.65	$28,655.20	211,169	4
2026-01-26	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	1,580	41.65	$65,807.00	178,848	4
2026-01-12	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	21,142	37.43	$791,345.06	176,883	4
2026-01-12	Schundler, Russell	Officer	General Counsel	Direct	Sale	27,289	37.43	$1,021,427.27	579,394	4
2026-01-12	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	11,047	37.43	$413,489.21	156,700	4
2026-01-12	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	13,548	37.43	$507,101.64	184,174	4
2026-01-12	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	20,533	37.43	$768,550.19	154,514	4
2026-01-12	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	36,932	37.43	$1,382,364.76	350,919	4
2026-01-12	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Sale	66,610	37.43	$2,493,212.30	1,037,528	4
2026-01-12	Krepp, Sarah	Officer	Chief Human Resource Officer	Direct	Sale	13,165	37.43	$492,765.95	140,769	4
2025-12-01	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	1,166	32.19	$37,533.54	353,823	4
2025-12-01	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	303	32.19	$9,753.57	155,031	4
2025-12-01	Schundler, Russell	Officer	General Counsel	Direct	Sale	1,072	32.19	$34,507.68	577,288	4
2025-12-01	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	693	32.19	$22,307.67	175,868	4
2025-12-01	Krepp, Sarah	Officer	Chief Human Resource Officer	Direct	Sale	221	32.19	$7,113.99	141,218	4
2025-12-01	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	831	32.19	$26,749.89	154,506	4
2025-11-18	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	35,656	30.03	$1,070,749.68	174,998	4
2025-11-07	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	29,004	25.11	$728,290.44	155,334	4
2025-11-05	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	71,381	27.00	$1,927,287.00	176,549	4
2025-10-27	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	1,073	22.93	$24,603.89	184,338	4
2025-10-27	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	692	22.93	$15,867.56	174,998	4
2025-10-13	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	11,630	23.41	$272,258.30	352,646	4
2025-10-13	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	4,900	23.41	$114,709.00	153,462	4
2025-10-13	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	3,670	23.41	$85,914.70	175,690	4
2025-10-13	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	5,327	23.41	$124,705.07	247,930	4
2025-10-13	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Sale	20,261	23.41	$474,310.01	1,032,973	4
2025-10-13	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	1,238	23.41	$28,981.58	185,411	4
2025-10-13	Schundler, Russell	Officer	General Counsel	Direct	Sale	7,839	23.41	$183,510.99	576,017	4
2025-10-13	Krepp, Sarah	Officer	Chief Human Resource Officer	Direct	Sale	1,691	23.41	$39,586.31	141,439	4
2025-09-15	Singh, Raman	Director	-	Direct	Sale	45,524	25.81	$1,174,974.44	31,255	4
2025-09-03	Singh, Raman	Director	-	Direct	Sale	7,500	29.42	$220,650.00	31,255	4
2025-09-02	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	451	29.05	$13,101.55	172,980	4
2025-09-02	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	1,148	29.05	$33,349.40	358,448	4
2025-09-02	Schundler, Russell	Officer	General Counsel	Direct	Sale	1,063	29.05	$30,880.15	580,098	4
2025-09-02	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	70,692	28.76	$2,033,101.92	155,254	4
2025-09-02	Manning, Paul B	Director	-	Indirect	Sale	328,268	28.90	$9,486,945.20	430,828	4
2025-08-29	Krepp, Sarah	Officer	Chief Human Resource Officer	Direct	Sale	209	29.05	$6,071.45	143,130	4
2025-08-29	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	296	29.05	$8,598.80	186,649	4
2025-08-28	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	20,000	27.85	$557,000.00	249,727	4
2025-08-19	Horobin, Joanna	Director	-	Direct	Sale	5,000	27.17	$135,850.00	33,755	4
2025-08-15	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	20,000	26.18	$523,600.00	356,412	4
2025-08-05	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	30,000	20.00	$600,000.00	376,412	4
2025-07-28	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	1,063	19.54	$20,771.02	186,105	4
2025-07-28	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	454	19.54	$8,871.16	193,180	4
2025-07-21	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	2,526	14.54	$36,728.04	268,887	4
2025-07-14	Krepp, Sarah	Officer	Chief Human Resource Officer	Direct	Sale	2,673	14.28	$38,170.44	142,499	4
2025-07-14	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	11,580	14.28	$165,362.40	406,412	4
2025-07-14	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	2,576	14.28	$36,785.28	193,634	4
2025-07-14	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Sale	20,252	14.28	$289,198.56	1,038,560	4
2025-07-14	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	4,797	14.28	$68,501.16	223,231	4
2025-07-14	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	5,327	14.28	$76,069.56	271,413	4
2025-07-14	Boyle, Dana	Officer	Chief Accounting Officer	Direct	Sale	1,193	14.28	$17,036.04	187,168	4
2025-07-14	Schundler, Russell	Officer	General Counsel	Direct	Sale	7,836	14.28	$111,898.08	577,977	4
2025-06-04	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	6,656	16.97	$112,952.32	224,921	4
2025-06-04	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	7,597	16.97	$128,921.09	273,209	4
2025-06-04	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	3,597	16.97	$61,041.09	193,735	4
2025-06-04	Schundler, Russell	Officer	General Counsel	Direct	Sale	8,460	16.97	$143,566.20	582,054	4
2025-06-04	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Sale	30,610	16.97	$519,451.70	1,044,979	4
2025-06-04	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	14,777	16.97	$250,765.69	412,164	4
2025-06-02	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	581	16.74	$9,725.94	216,038	4
2025-06-02	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	451	16.74	$7,549.74	184,961	4
2025-06-02	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	859	16.74	$14,379.66	397,800	4
2025-06-02	Schundler, Russell	Officer	General Counsel	Direct	Sale	923	16.74	$15,451.02	571,722	4
2025-04-28	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	455	14.24	$6,479.20	183,849	4
2025-04-21	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	2,450	13.67	$33,491.50	263,152	4
2025-04-15	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	3,406	13.57	$46,219.42	214,744	4
2025-04-14	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	1,856	13.57	$25,185.92	184,304	4
2025-04-14	Schundler, Russell	Officer	General Counsel	Direct	Sale	5,964	13.57	$80,931.48	570,301	4
2025-04-14	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	3,714	13.57	$50,398.98	265,602	4
2025-04-14	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	8,283	13.57	$112,400.31	396,315	4
2025-04-14	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Sale	14,130	13.57	$191,744.10	1,006,420	4
2025-03-03	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	451	15.45	$6,967.95	182,254	4
2025-03-03	Schundler, Russell	Officer	General Counsel	Direct	Sale	930	15.45	$14,368.50	576,265	4
2025-03-03	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	874	15.45	$13,503.30	404,598	4
2025-03-03	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	592	15.45	$9,146.40	218,150	4
2025-01-27	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	445	14.20	$6,319.00	179,770	4
2025-01-21	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	2,445	13.00	$31,785.00	267,943	4
2025-01-14	Schundler, Russell	Officer	General Counsel	Direct	Sale	16,393	11.78	$193,109.54	573,478	4
2025-01-14	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	8,362	11.78	$98,504.36	215,494	4
2025-01-14	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	4,809	11.78	$56,650.02	180,215	4
2025-01-14	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	6,249	11.78	$73,613.22	270,388	4
2025-01-14	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	23,370	11.78	$275,298.60	401,755	4
2025-01-14	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Sale	22,343	11.78	$263,200.54	1,019,177	4
2024-12-02	Schundler, Russell	Officer	General Counsel	Direct	Sale	1,063	11.51	$12,235.13	487,328	4
2024-12-02	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	1,091	11.51	$12,557.41	312,328	4
2024-12-02	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	546	11.51	$6,284.46	154,127	4
2024-12-02	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	455	11.51	$5,237.05	119,223	4
2024-10-28	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	459	11.31	$5,191.29	118,115	4/A
2024-10-18	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	2,526	11.19	$28,265.94	204,857	4
2024-10-14	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	1,146	11.11	$12,732.06	118,574	4
2024-10-14	Schundler, Russell	Officer	General Counsel	Direct	Sale	2,576	11.11	$28,619.36	486,048	4
2024-10-14	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	1,527	11.11	$16,964.97	152,798	4
2024-10-14	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	3,892	11.11	$43,240.12	311,076	4
2024-10-14	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Sale	8,053	11.11	$89,468.83	812,193	4
2024-10-14	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	2,260	11.11	$25,108.60	207,383	4
2024-09-12	Manning, Paul B	Director	-	Indirect	Purchase	337,078	8.90	$2,999,994.20	816,311	4
2024-09-03	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	455	9.50	$4,322.50	115,814	4
2024-09-03	Schundler, Russell	Officer	General Counsel	Direct	Sale	710	9.50	$6,745.00	488,624	4
2024-09-03	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	546	9.50	$5,187.00	154,325	4
2024-09-03	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	1,079	9.50	$10,250.50	314,968	4
2024-08-30	Caligan, Partners Lp, Joh…	Director,TenPercentOwner	-	Indirect	Purchase	150,000	9.51	$1,426,500.00	6,994,997	4
2024-08-30	Caligan, Partners Lp, Joh…	Director,TenPercentOwner	-	Indirect	Sale	150,000	9.51	$1,426,500.00	6,844,997	4
2024-07-26	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	1,833	11.44	$20,969.52	113,393	4
2024-07-19	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	1,873	11.13	$20,846.49	208,329	4
2024-07-12	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	3,906	12.53	$48,942.18	312,389	4
2024-07-12	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	1,528	12.53	$19,145.84	151,682	4
2024-07-12	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	1,470	12.53	$18,419.10	210,202	4
2024-07-12	Schundler, Russell	Officer	General Counsel	Direct	Sale	1,985	12.53	$24,872.05	485,676	4
2024-07-12	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Sale	8,053	12.53	$100,904.09	818,932	4
2024-07-12	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	1,146	12.53	$14,359.38	115,226	4
2024-06-03	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	546	14.55	$7,944.30	153,210	4
2024-06-03	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	455	14.55	$6,620.25	112,465	4
2024-06-03	Schundler, Russell	Officer	General Counsel	Direct	Sale	710	14.55	$10,330.50	487,661	4
2024-06-03	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	1,094	14.55	$15,917.70	316,295	4
2024-04-19	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	1,649	13.68	$22,558.32	211,672	4
2024-04-12	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Sale	8,360	14.58	$121,888.80	826,985	4
2024-04-12	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	1,189	14.58	$17,335.62	111,537	4
2024-04-12	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	3,136	14.58	$45,722.88	315,045	4
2024-04-12	Schundler, Russell	Officer	General Counsel	Direct	Sale	2,060	14.58	$30,034.80	486,027	4
2024-04-12	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	1,525	14.58	$22,234.50	213,321	4
2024-04-12	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	1,585	14.58	$23,109.30	151,881	4
2024-03-18	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	6,108	15.82	$96,628.56	153,466	4
2024-03-18	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	7,530	15.82	$119,124.60	214,846	4
2024-03-18	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Sale	28,583	15.82	$452,183.06	835,345	4
2024-03-18	Kaseta, Michael	Officer	CFO and COO	Direct	Sale	12,166	15.82	$192,466.12	318,181	4
2024-03-18	Schundler, Russell	Officer	General Counsel	Direct	Sale	8,653	15.82	$136,890.46	488,087	4
2024-03-18	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	4,657	15.66	$72,928.62	108,640	4
2024-02-29	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	455	14.17	$6,447.35	97,412	4
2024-02-29	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	546	14.17	$7,736.82	159,574	4
2023-12-18	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	77	7.70	$592.90	54,932	4
2023-12-18	Saggar, Rajeev	Officer	Chief Medical Officer	Direct	Sale	14,887	7.42	$110,461.54	164,099	4
2023-12-14	Manning, Paul B	Director	-	Direct	Purchase	279,330	7.16	$2,000,002.80	279,330	4
2023-12-14	Caligan, Partners Lp, Joh…	Director,TenPercentOwner	-	Indirect	Purchase	1,117,318	7.16	$7,999,996.88	11,280,945	4
2023-12-14	Jeffs, Roger	Director,Officer	Chief Executive Officer	Direct	Purchase	139,665	7.16	$1,000,001.40	640,805	4
2023-11-30	Lippe, Robert A	Officer	Chief Operations Officer	Direct	Sale	497	7.28	$3,618.16	193,788	4
2023-11-30	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	452	7.28	$3,290.56	54,478	4
2023-11-30	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	542	7.28	$3,945.76	106,737	4
2023-09-19	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	75	6.51	$488.25	53,637	4
2023-08-31	Lippe, Robert A	Officer	Chief Operations Officer	Direct	Sale	505	6.88	$3,474.40	192,567	4
2023-08-31	Adair, Jason	Officer	Chief Business Officer	Direct	Sale	445	6.88	$3,061.60	53,452	4
2023-08-31	Moomaw, Scott	Officer	Chief Commercial Officer	Direct	Sale	537	6.88	$3,694.56	105,404	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

68.14%

Inst. Shares: 59,970,082

Shares Outstanding: 88,006,244

2025-12-31

71.23%

Inst. Shares: 61,298,385

Shares Outstanding: 86,059,101

2025-09-30

74.54%

Inst. Shares: 64,356,951

Shares Outstanding: 86,333,772

2025-06-30

66.65%

Inst. Shares: 57,046,082

Shares Outstanding: 85,588,108

2025-03-31

63.76%

Inst. Shares: 54,302,984

Shares Outstanding: 85,172,696

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	59,970,082	88,006,244	68.14%
2025-12-31	61,298,385	86,059,101	71.23%
2025-09-30	64,356,951	86,333,772	74.54%
2025-06-30	57,046,082	85,588,108	66.65%
2025-03-31	54,302,984	85,172,696	63.76%
2024-12-31	50,418,381	78,707,503	64.06%
2024-09-30	51,811,112	78,316,820	66.16%
2024-06-30	45,906,047	76,435,831	60.06%
2024-03-31	45,835,271	75,393,907	60.79%
2023-12-31	35,070,885	64,993,476	53.96%
2023-09-30	27,911,166	64,857,508	43.03%
2023-06-30	28,399,266	64,788,482	43.83%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Liquidia Corp (LQDA) — SEC Financial Statements & Analysis

Liquidia Corp (LQDA) is a pharmaceutical preparations company, incorporated in DE. Liquidia Corp trades on Nasdaq as: LQDA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Liquidia Corp reported a 2233.65% year-over-year revenue growth, a Gross Profit Margin of 97.20% (TTM), a Debt-to-Equity ratio of 1.67x, a Price-to-Sales (P/S) ratio of 15.72x (TTM), a Price-to-Book (P/B) ratio of 36.32x (TTM), at a market cap of $7.09B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 2233.65%
Gross Profit Margin TTM: 97.20%
Debt To Equity: 1.67x
P/S TTM: 15.72x
P/B TTM: 36.32x
Market Cap: $7.09B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Liquidia Corp in?

Liquidia Corp (LQDA) operates in the Pharmaceutical Preparations industry.

What is LQDA's market cap?

Liquidia Corp (LQDA) has a market capitalization of $7.09B as of 2026-06-30.

What is LQDA's P/E ratio?

Liquidia Corp (LQDA)'s trailing twelve month P/E ratio is 51.13x as of 2026-06-30.

What exchange does LQDA trade on?

Liquidia Corp (LQDA) trades on the Nasdaq.

Where is Liquidia Corp incorporated?

Liquidia Corp is incorporated in DE.

Liquidia Corp

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Liquidia Corp (LQDA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Liquidia Corp (LQDA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.